CRISPR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. 

CEO
Samarth Kulkarni
CEOSamarth Kulkarni
Employees
407
Employees407
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2013
Founded2013
Employees
407
Employees407

CRSP Key Statistics

Market cap
3.96B
Market cap3.96B
Price-Earnings ratio
-16.74
Price-Earnings ratio-16.74
Dividend yield
Dividend yield
Average volume
2.12M
Average volume2.12M
High today
$47.60
High today$47.60
Low today
$46.02
Low today$46.02
Open price
$47.21
Open price$47.21
Volume
188.50K
Volume188.50K
52 Week high
$91.10
52 Week high$91.10
52 Week low
$43.42
52 Week low$43.42

Analyst ratings

50%

of 30 ratings
Buy
50%
Hold
40%
Sell
10%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.